1. Home
  2. RHI vs PTCT Comparison

RHI vs PTCT Comparison

Compare RHI & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$26.80

Market Cap

3.3B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$77.48

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RHI
PTCT
Founded
1948
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
5.3B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RHI
PTCT
Price
$26.80
$77.48
Analyst Decision
Sell
Buy
Analyst Count
7
17
Target Price
$40.00
$73.76
AVG Volume (30 Days)
2.5M
2.3M
Earning Date
10-22-2025
11-04-2025
Dividend Yield
8.81%
N/A
EPS Growth
N/A
N/A
EPS
1.54
8.94
Revenue
$5,458,499,000.00
$1,779,150,000.00
Revenue This Year
N/A
$128.32
Revenue Next Year
$1.14
N/A
P/E Ratio
$17.39
$8.64
Revenue Growth
N/A
97.54
52 Week Low
$25.22
$35.95
52 Week High
$78.41
$87.50

Technical Indicators

Market Signals
Indicator
RHI
PTCT
Relative Strength Index (RSI) 42.15 54.29
Support Level $26.76 $73.03
Resistance Level $28.01 $79.03
Average True Range (ATR) 0.91 3.38
MACD 0.23 -0.70
Stochastic Oscillator 55.58 29.37

Price Performance

Historical Comparison
RHI
PTCT

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: